Royal London Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,278	Closed	-$343K	–	725
2025 Q1	$343K	Sell	2,278 -14,147	-86%	-$2.37M	﹤0.01%	708
2024 Q4	$3.03M	Buy	16,425 +991	+6%	+$191K	0.01%	583
2024 Q3	$3.04M	Sell	15,434 -33	-0.2%	-$6.86K	0.01%	588
2024 Q2	$3.2M	Hold	15,467	–	–	0.01%	589
2024 Q1	$4.19M	Sell	15,467 -440	-3%	-$105K	0.01%	573
2023 Q4	$3.76M	Sell	15,907 -305	-2%	-$60K	0.01%	582
2023 Q3	$3.18M	Hold	16,212	–	–	0.01%	595
2023 Q2	$3.41M	Hold	16,212	–	–	0.01%	576
2023 Q1	$3.27M	Sell	16,212 -341	-2%	-$77.3K	0.01%	559
2022 Q4	$3.6M	Hold	16,553	–	–	0.02%	531
2022 Q3	$3.26M	Sell	16,553 -1,153	-7%	-$249K	0.02%	538
2022 Q2	$3.79M	Buy	17,706 +616	+4%	+$151K	0.02%	521
2022 Q1	$4.85M	Buy	17,090 +4,784	+39%	+$1.48M	0.02%	508
2021 Q4	$4.64M	Buy	12,306 +8,958	+268%	+$3.48M	0.02%	512
2021 Q3	$1.38M	Buy	+3,348	New	+$1.39M	0.01%	635